[{"data": {"name": "PARP1 expression, activity and <i>ex vivo</i> sensitivity to the PARP inhibitor, talazoparib (BMN 673), in chronic lymphocytic leukaemia", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ashleigh Herriott", "@type": "Person"}, {"name": "Susan J. Tudhope", "@type": "Person"}, {"name": "Gesa Junge", "@type": "Person"}, {"name": "Natalie Rodrigues", "@type": "Person"}, {"name": "Miranda J. Patterson", "@type": "Person"}, {"name": "Laura Woodhouse", "@type": "Person"}, {"name": "John Lunec", "@type": "Person"}, {"name": "Jill E. Hunter", "@type": "Person"}, {"name": "Evan A. Mulligan", "@type": "Person"}, {"name": "Michael Cole", "@type": "Person"}, {"name": "Lisa M. Allinson", "@type": "Person"}, {"name": "Jonathan P. Wallis", "@type": "Person"}, {"name": "Scott Marshall", "@type": "Person"}, {"name": "Evelyn Wang", "@type": "Person"}, {"name": "Nicola J. Curtin", "@type": "Person"}, {"name": "Elaine Willmore", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4791280?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Impact Journals, LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.18632/oncotarget.6287", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCFPwVLh4swaj-CTcYHiAiuyJHA-CDDFTFtw3Tx8F-CRHqrzQmgTx2w", "propertyID": "ISCC"}], "datePublished": "2015-11-03"}, "schema": "schema.org", "mediatype": "application/ld+json"}]